Sahil Chopra
Direktor/Vorstandsmitglied bei Indapta Therapeutics, Inc.
Aktive Positionen von Sahil Chopra
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01.01.2023 | - |
Indapta Therapeutics, Inc.
Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | 01.02.2022 | - |
Karriereverlauf von Sahil Chopra
Ehemalige bekannte Positionen von Sahil Chopra
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELEVATION ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 01.11.2020 | 01.10.2021 |
Ausbildung von Sahil Chopra
Weill Cornell Graduate School of Medical Sciences | Graduate Degree |
Maharshi Dayanand University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Indien | 2 |
Operativ
Director/Board Member | 2 |
Private Equity Investor | 1 |
Graduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ELEVATION ONCOLOGY, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | Finance |
Indapta Therapeutics, Inc.
Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Health Technology |
- Börse
- Insiders
- Sahil Chopra
- Erfahrung